Relacore was designed to mitigate the Metabolic Syndrome and reduce the accumulation of stress-induced cortisol, a leading cause of belly fat accumulation.

The Metabolic Syndrome, which affects about one-quarter of all adults in the U.S., has emerged as just as strong a contributor to early heart disease as cigarette smoking. The Metabolic Syndrome, also known as syndrome X or insulin resistance syndrome, is a constellation of metabolic risk factors that significantly increases the risk for coronary events.

The metabolic syndrome is identified by the presence of three or more of the following:

Abdominal Obesity
Waist circumference greater than 40 inches in men or greater than 35 inches in women

Triglycerides
150 mg/dL; HDL cholesterol less than 40 mg/dL in men or less than 50 mg/dL in women

Blood Pressure
130/85 mmHg; and fasting glucose 110 mg/dL.